These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

98 related articles for article (PubMed ID: 12851916)

  • 41. [Rheumatoid arthritis, inflammation, and atherosclerosis].
    Hürlimann D; Enseleit F; Ruschitzka F
    Herz; 2004 Dec; 29(8):760-8. PubMed ID: 15599672
    [TBL] [Abstract][Full Text] [Related]  

  • 42. Quotidian hemodialysis and inflammation associated with chronic kidney disease.
    Hamlett L; Haragsim L
    Adv Chronic Kidney Dis; 2007 Jul; 14(3):e35-42. PubMed ID: 17603973
    [TBL] [Abstract][Full Text] [Related]  

  • 43. Impact of kidney disease and blood pressure on the development of cardiovascular disease: an overview from the Japan Arteriosclerosis Longitudinal Study.
    Ninomiya T; Kiyohara Y; Tokuda Y; Doi Y; Arima H; Harada A; Ohashi Y; Ueshima H;
    Circulation; 2008 Dec; 118(25):2694-701. PubMed ID: 19106392
    [TBL] [Abstract][Full Text] [Related]  

  • 44. Bone mineral density in end-stage renal disease patients: association with wasting, cardiovascular disease and mortality.
    Matsubara K; Suliman ME; Qureshi AR; Axelsson J; Martola L; Heimbürger O; Barany P; Stenvinkel P; Lindholm B
    Blood Purif; 2008; 26(3):284-90. PubMed ID: 18421213
    [TBL] [Abstract][Full Text] [Related]  

  • 45. [Heart rate and sympathetic risk].
    Siché JP
    Ann Cardiol Angeiol (Paris); 1998 Jun; 47(6):404-10. PubMed ID: 9772959
    [TBL] [Abstract][Full Text] [Related]  

  • 46. New cardiovascular risk factors: homocysteine and vitamins involved in homocysteine metabolism.
    De Caterina R; Zampolli A; Madonna R; Fioretti P; Vanuzzo D
    Ital Heart J; 2004 Jun; 5 Suppl 6():19S-24S. PubMed ID: 15185912
    [TBL] [Abstract][Full Text] [Related]  

  • 47. Clinical use and rational management of homocysteine, folic acid, and B vitamins in cardiovascular and thrombotic diseases.
    Stanger O; Herrmann W; Pietrzik K; Fowler B; Geisel J; Dierkes J; Weger M
    Z Kardiol; 2004 Jun; 93(6):439-53. PubMed ID: 15252738
    [TBL] [Abstract][Full Text] [Related]  

  • 48. Relationship between chronic inflammation and cardiovascular risk factors in children on maintenance hemodialysis.
    Cengiz N; Baskin E; Agras PI; Sezgin N; Saatci U
    Transplant Proc; 2005 Sep; 37(7):2915-7. PubMed ID: 16213260
    [TBL] [Abstract][Full Text] [Related]  

  • 49. Traditional and emerging risk factors for cardiovascular disease.
    Eaton CB
    Prim Care; 2005 Dec; 32(4):963-76, vii. PubMed ID: 16326222
    [TBL] [Abstract][Full Text] [Related]  

  • 50. [Cardiovascular risk markers in hemodialysis].
    Urso S; Milone F; Garozzo M; Cannavò ME; Biondi A; Battaglia G
    G Ital Nefrol; 2004; 21 Suppl 30():S212-6. PubMed ID: 15750988
    [TBL] [Abstract][Full Text] [Related]  

  • 51. Advances in the prevention and treatment of cardiovascular disease.
    Weisfeldt ML; Zieman SJ
    Health Aff (Millwood); 2007; 26(1):25-37. PubMed ID: 17211011
    [TBL] [Abstract][Full Text] [Related]  

  • 52. Association between novel indices of malnutrition-inflammation complex syndrome and cardiovascular disease in hemodialysis patients.
    Terrier N; Senécal L; Dupuy AM; Jaussent I; Delcourt C; Leray H; Rafaelsen S; Bosc JY; Maurice F; Canaud B; Cristol JP
    Hemodial Int; 2005 Apr; 9(2):159-68. PubMed ID: 16191065
    [TBL] [Abstract][Full Text] [Related]  

  • 53. [Atherosclerosis and uremia: signifance of non-traditional risk factors].
    Hörl WH
    Wien Klin Wochenschr; 2003 Apr; 115(7-8):220-34. PubMed ID: 12778774
    [TBL] [Abstract][Full Text] [Related]  

  • 54. "New" cardiovascular risk factors in patients with chronic kidney disease: role of folic acid treatment.
    Bayés B; Pastor MC; Bonal J; Romero R
    Kidney Int Suppl; 2005 Jan; (93):S39-43. PubMed ID: 15613067
    [TBL] [Abstract][Full Text] [Related]  

  • 55. Sympathetic overactivity in renal disease: a window to understand progression and cardiovascular complications of uraemia?
    Rump LC; Amann K; Orth S; Ritz E
    Nephrol Dial Transplant; 2000 Nov; 15(11):1735-8. PubMed ID: 11071955
    [No Abstract]   [Full Text] [Related]  

  • 56. Cardiovascular risk factors in children and prevention of adult atherosclerosis.
    Nicklas TA; Arbeit ML; Srinivasan SR; Berenson GS
    Bol Asoc Med P R; 1991 Nov; 83(11):502-4. PubMed ID: 1811600
    [No Abstract]   [Full Text] [Related]  

  • 57. Inflammatory and atherosclerotic interactions in the depleted uremic patient.
    Stenvinkel P
    Blood Purif; 2001; 19(1):53-61. PubMed ID: 11114578
    [TBL] [Abstract][Full Text] [Related]  

  • 58. Chronic renal failure: a cardiovascular risk factor.
    Fort J
    Kidney Int Suppl; 2005 Dec; (99):S25-9. PubMed ID: 16336573
    [TBL] [Abstract][Full Text] [Related]  

  • 59. Approaches to the reversal of malnutrition, inflammation, and atherosclerosis in end-stage renal disease.
    Caglar K; Hakim RM; Ikizler TA
    Nutr Rev; 2002 Nov; 60(11):378-87. PubMed ID: 12462522
    [TBL] [Abstract][Full Text] [Related]  

  • 60. Inflammation in uremic patients: what is the link?
    Galle J; Seibold S; Wanner C
    Kidney Blood Press Res; 2003; 26(2):65-75. PubMed ID: 12771529
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 5.